Inhibition of stress-activated P38 mitogen-activated protein kinase induces low-density lipoprotein receptor expression

Trends in Cardiovascular Medicine

Volumn 9, Issue 7, 1999, Pages 201-205

  Mehta, Kamal D ^a   Miller, Lance ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009870909     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00021-9     Document Type: Review

References (38)

1. Alessi DR, Cuenda A, Cohen P, et al.: 1995. PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27,489-27,494.
2. Berger DF, Starzec JJ, Mason EB, et al.: 1980. The effects of differential psychological stress on plasma cholesterol levels in rats. Psychom Med 42:481-492.
3. Berra E, Diaz-Meco MT, Moscat J: 1998. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273:10,792-10,797.
4. Berra E, Municio MM, Sanz L, et al.: 1997. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol Cell Biol 17:4346-4354.
5. Brennan FX, Job RFS, Watkins LR, et al.: 1992. Total plasma cholesterol levels of rats are increased following only three sessions of tailshock. Life Sci 50:945-950.
6. Brown MS, Goldstein JL: 1986. A receptor mediated pathway for cholesterol homeostasis. Science 232:34-47.
7. Cuenda A, Roise J, Doza YN, et al.: 1995. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
8. Daum G, Kalmes A, Levkau B, et al.: 1998. Pervanadate inhibits mitogen-activated protein kinase kinase-1 in a p38MAPK-dependent manner. FEBS Lett 427:271-274.
9. MAPK cascade is sufficient to induce LDL receptor expression. J Lipid Res 40:1911-1919.
10. Enslen H, Raingeaud J, Davis RJ: 1998. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 273:1741-1748.
11. Friedman M, Rosenman RH, Carroll V: 1958. Changes in the serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress. Circulation 17:852-861.
12. Goldstein JL, Brown MS: 1990. Regulation of the mevalonate pathway. Nature 343:425-430.
13. Gum RJ, McLaughlin MM, Kumar S, et al.: 1998. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem 273:15,605-15,610.
14. Hunter JJ, Chien KR: 1999. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341:1276-1283.
15. Ip YT, Davis RJ: 1998. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 10:205-219.
16. Kalmes A, Deou J, Clowes AW, et al.: 1999. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett 444:71-74.
17. Kannel WB, Castelli WP, Gordon T, et al.: 1971. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Int Med 74:1-12.
18. Kumar A, Chambers TC, Cloud-Heflin BA, et al.: 1997. Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation. J Lipid Res 38:199-207.
19. MAPK in IL-1β/TNF-induced LDL receptor expression in HepG2 cells. J Biol Chem 273:15,742-15,748.
20. Lee JC, Laydon JT, McDonnell PC, et al.: 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
21. Lewis TS, Shapiro PS, Ahn NG: 1998. Signal transduction through MAP kinase cascade. Adv Cancer Res 74:49-139.
22. Li C, Kraemer FB, Ahlborn TE, Liu J: 1999. Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDL receptor promoter. J Biol Chem 274:6747-6753.
23. Madhani HD, Fink GR: 1998. The riddle of MAP kinase signaling specificity. Trends Genet 14:151-155.
24. McCann BS, Warnick GR, Knopp RH: 1990. Changes in plasma lipids and dietary intake accompanying shifts in perceived workload and stress. Psychom Med 52:97-108.
25. Olubadewo JO, Wingard M, Washington B, et al.: 1994. The effects of stress on lipoproteins and catecholamines in rats. Cell Mol Biol 40:1201-1206.
26. Robinson MJ, Cobb MH: 1997. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186.
27. Rosenman RH: 1993. Relationship of neurogenic and psychological factors to the regulation and variability of serum lipids. Stress Med 9:133-140.
28. Rothfeld B, Pare WP, Varady A, et al.: 1973. Effect of glucagon and stress on cholesterol metabolism and deposition in tissues. Biochem Med 7:292-298.
29. Sane AS, Kukreti SC: 1978. Effect of preoperative stress on serum cholesterol level in humans. Experientia 34:213-214.
30. Schaeffer HJ, Weber MJ: 1999. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-2444.
31. MAPK cascade. J Biol Chem 274:19,593-19,600.
32. Thomas F, Pombo C, Avruch JA, et al.: 1996. Stress-activated protein kinases in cardiovascular disease. Circ Res 78:947-953.
33. Tong L, Pav S, White DM, et al.: 1997. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol 4:311-316.
34. Treisman R: 1996. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 9:205-215.
35. van Doornen LJP: 1986. Sex differences in physiology reactions to real life stress and their relationship to psychological variables. Psychophysiology 23:657-662.
36. Wang Y, Huang S, Sah VP, et al.: 1998. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273:2161-2168.
37. Wilson KP, McCaffrey PG, Hsiao K, et al.: 1997. The structural basis for the specific-ity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem Biol 4:423-431.
38. Xia Z, Dickens M, Raingeaud J, et al.: 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.